Benefits of a Disease Management Program for Sickle Cell Disease in Germany 2011–2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome

Sickle Cell Disease (SCD) is the most common monogenic disorder globally but qualifies as a rare disease in Germany. In 2012, the German Society for Paediatric Oncology and Haematology (GPOH) mandated a consortium of five university hospitals to develop a disease management program for patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunz, Joachim B., Schlotmann, Andreas, Daubenbüchel, Andrea, Lobitz, Stephan, Jarisch, Andrea, Grosse, Regine, Cario, Holger, Oevermann, Lena, Hakimeh, Dani, Tagliaferri, Laura, Kulozik, Andreas E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509263/
https://www.ncbi.nlm.nih.gov/pubmed/34640578
http://dx.doi.org/10.3390/jcm10194543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509263/
https://www.ncbi.nlm.nih.gov/pubmed/34640578
http://dx.doi.org/10.3390/jcm10194543

Ejemplares similares